3,140
Views
4
CrossRef citations to date
0
Altmetric
Laboratory Study

15-Hydroxyprostaglandin dehydrogenase inhibitor prevents contrast-induced acute kidney injury

, , , , , , , & show all
Pages 168-179 | Received 14 Aug 2020, Accepted 21 Dec 2020, Published online: 17 Jan 2021

References

  • van der Molen AJ, Reimer P, Dekkers IA, et al. Post-contrast acute kidney injury – part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018;28:2845–2855.
  • ACR Committee on Drugs and Contrast Media. ACR manual on contrast media, version 10.3. 2020.
  • Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006; 69:S11–S15.
  • Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005;172:1461–1471.
  • Neumann FJ, Sousa-Uva M, Ahlsson A, et al., ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165.
  • Jeong BY, Lee HY, Park CG, Kang J, et al. Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury. PLoS One. 2018;13:e0191034.
  • Shen J, Wang L, Jiang N, et al. NLRP3 inflammasome mediates contrast media-induced acute kidney injury by regulating cell apoptosis. Sci Rep. 2016;6:34682.
  • From AM, Bartholmai BJ, Williams AW, et al. Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc. 2008;83:1095–1100.
  • Goldenberg I, Chonchol M, Guetta V. Reversible acute kidney injury following contrast exposure and the risk of long-term mortality. Am J Nephrol. 2009;29:136–144.
  • Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, et al. Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies. Pharmacol Ther. 2017;180:99–112.
  • Weisbord SD, Gallagher M, Jneid H, et al., PRESERVE Trial Group. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med. 2018;378:603–614.
  • Cho A, Lee YK, Sohn SY. Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: a meta-analysis. Medicine (Baltimore). 2020;99:e19473.
  • Kolh P, Windecker S, Alfonso F, et al., European Society of Cardiology Committee for Practice Guidelines, Task Force on Myocardial Revascularization of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery, European Association of Percutaneous Cardiovascular Interventions. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2014;46:517–592.
  • Geng N, Zou D, Chen Y, et al. Prostaglandin E1 administration for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97:e11416.
  • Stacul F, van der Molen AJ, Reimer P, et al., Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527–2541.
  • Caiazza A, Russo L, Sabbatini M, et al. Hemodynamic and tubular changes induced by contrast media. Biomed Res Int. 2014;2014:578974.
  • Zhang Y, Desai A, Yang SY, et al. Tissue Regeneration. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science. 2015;348:aaa2340.
  • Eskildsen MP, Hansen PB, Stubbe J, et al. Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors. Hypertension. 2014;64:551–556.
  • Persson P, Fasching A, Teerlink T, et al. Cellular transport of L-arginine determines renal medullary blood flow in control rats, but not in diabetic rats despite enhanced cellular uptake capacity. Am J Physiol Renal Physiol. 2017;312:F278–F283.
  • Cheng W, Zhao F, Tang CY, et al. Comparison of iohexol and iodixanol induced nephrotoxicity, mitochondrial damage and mitophagy in a new contrast-induced acute kidney injury rat model. Arch Toxicol. 2018;92:2245–2257.
  • Sun S, Zhang T, Nie P, et al. A novel rat model of contrast-induced acute kidney injury. Int J Cardiol. 2014;172:e48–e50.
  • Seeliger E, Lenhard DC, Persson PB. Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies. Biomed Res Int. 2014;2014:358136.
  • Martensson J, Bellomo R. The rise and fall of NGAL in acute kidney injury. Blood Purif. 2014;37:304–310.
  • Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl. 2008;241:78–83.
  • Kolyada AY, Liangos O, Madias NE, et al. Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury. Am J Nephrol. 2008;28:203–209.
  • Romano G, Briguori C, Quintavalle C, et al. Contrast agents and renal cell apoptosis. Eur Heart J. 2008;29:2569–2576.
  • Oh HJ, Oh H, Nam BY, et al. The protective effect of klotho against contrast-associated acute kidney injury via the antioxidative effect. Am J Physiol Renal Physiol. 2019;317:F881–F889.
  • Vlachopanos G, Schizas D, Hasemaki N, et al. Pathophysiology of contrast-induced acute kidney injury (CIAKI). Curr Pharm Des. 2019;25:4642–4647.
  • van Rodijnen WF, Korstjens IJ, Legerstee N, et al. Direct vasoconstrictor effect of prostaglandin E2 on renal interlobular arteries: role of the EP3 receptor. Am J Physiol Renal Physiol. 2007;292:F1094–F1101.
  • Tang L, Loutzenhiser K, Loutzenhiser R. Biphasic actions of prostaglandin E(2) on the renal afferent arteriole: role of EP(3) and EP(4) receptors. Circ Res. 2000;86:663–670.
  • Imig JD, Breyer MD, Breyer RM. Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in mice. Am J Physiol Renal Physiol. 2002;283:F415–F422.